Jiateng Zhong

1.6k total citations
36 papers, 1.3k citations indexed

About

Jiateng Zhong is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Jiateng Zhong has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Cell Biology. Recurrent topics in Jiateng Zhong's work include Ubiquitin and proteasome pathways (11 papers), Endoplasmic Reticulum Stress and Disease (8 papers) and Autophagy in Disease and Therapy (7 papers). Jiateng Zhong is often cited by papers focused on Ubiquitin and proteasome pathways (11 papers), Endoplasmic Reticulum Stress and Disease (8 papers) and Autophagy in Disease and Therapy (7 papers). Jiateng Zhong collaborates with scholars based in China, United States and Myanmar. Jiateng Zhong's co-authors include Hiroyuki Inuzuka, Zhiwei Wang, Liankun Sun, Wenyi Wei, Jing Su, Jinsong Kang, Fazlul H. Sarkar, Lixin Wan, Xiaoxia Kong and Hongyu Zhang and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jiateng Zhong

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiateng Zhong China 20 937 312 258 252 195 36 1.3k
Mohamed Elgendy Italy 13 766 0.8× 413 1.3× 209 0.8× 199 0.8× 142 0.7× 21 1.2k
Zhirong Shen China 16 853 0.9× 327 1.0× 203 0.8× 192 0.8× 126 0.6× 37 1.3k
Jiqin Lian China 19 905 1.0× 411 1.3× 300 1.2× 207 0.8× 116 0.6× 43 1.3k
Gong-Kan Feng China 25 1.0k 1.1× 476 1.5× 365 1.4× 391 1.6× 213 1.1× 39 1.8k
Alan Zwart United States 20 736 0.8× 300 1.0× 314 1.2× 327 1.3× 293 1.5× 39 1.4k
Jayshree L. Hirpara Singapore 16 746 0.8× 207 0.7× 257 1.0× 204 0.8× 87 0.4× 28 1.1k
Xu Di United States 19 790 0.8× 378 1.2× 216 0.8× 336 1.3× 102 0.5× 25 1.4k
Xing Guo China 21 974 1.0× 175 0.6× 250 1.0× 257 1.0× 187 1.0× 61 1.4k
Yancun Yin China 18 654 0.7× 144 0.5× 232 0.9× 198 0.8× 186 1.0× 33 1.2k
Chang Yeob Han South Korea 21 611 0.7× 414 1.3× 153 0.6× 174 0.7× 224 1.1× 35 1.2k

Countries citing papers authored by Jiateng Zhong

Since Specialization
Citations

This map shows the geographic impact of Jiateng Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiateng Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiateng Zhong more than expected).

Fields of papers citing papers by Jiateng Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiateng Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiateng Zhong. The network helps show where Jiateng Zhong may publish in the future.

Co-authorship network of co-authors of Jiateng Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Jiateng Zhong. A scholar is included among the top collaborators of Jiateng Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiateng Zhong. Jiateng Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Feng, Sijia, et al.. (2025). Tumor-promoting effect and tumor immunity of SRSFs. Frontiers in Cell and Developmental Biology. 13. 1527309–1527309. 2 indexed citations
4.
Lv, Mengmeng, Sheng Guo, Xinyu Zhang, et al.. (2023). Attenuated Salmonella-delivered PD-1 siRNA enhances the antitumor effects of EZH2 inhibitors in colorectal cancer. International Immunopharmacology. 124(Pt A). 110918–110918. 2 indexed citations
5.
Hu, Yuhan, Shuai Ma, Pei Yu, et al.. (2022). FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner. Cell Death and Disease. 13(11). 941–941. 24 indexed citations
6.
Jia, Huijie, Jing Guo, Zhiang Liu, et al.. (2022). High expression of CD28 enhanced the anti-cancer effect of siRNA-PD-1 through prompting the immune response of melanoma-bearing mice. International Immunopharmacology. 105. 108572–108572. 6 indexed citations
7.
Li, Yongzhen, Jingyu Guo, Mengyao Wang, et al.. (2022). Integrated proteomic and phosphoproteomic analysis for characterization of colorectal cancer. Journal of Proteomics. 274. 104808–104808. 9 indexed citations
8.
Zhong, Jiateng, Shuya Lu, Qian Li, et al.. (2022). Role of endoplasmic reticulum stress in apoptosis induced by HK2 inhibitor and its potential as a new drug combination strategy. Cell Stress and Chaperones. 27(3). 273–283. 6 indexed citations
9.
Zhong, Jiateng, Pei Yu, Xinlai Qian, et al.. (2022). The Landscape of the Tumor-Infiltrating Immune Cell and Prognostic Nomogram in Colorectal Cancer. Frontiers in Genetics. 13. 891270–891270. 5 indexed citations
10.
Xu, Libo, Jiateng Zhong, Baofeng Guo, et al.. (2016). miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1. Tumor Biology. 37(9). 12023–12032. 29 indexed citations
11.
Liu, Jia, Ning Wu, Leina Ma, et al.. (2014). p38 MAPK Signaling Mediates Mitochondrial Apoptosis in Cancer Cells Induced by Oleanolic Acid. Asian Pacific Journal of Cancer Prevention. 15(11). 4519–4525. 58 indexed citations
12.
Zhong, Jiateng, Kohei Ogura, Zhiwei Wang, & Hiroyuki Inuzuka. (2013). Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis.. PubMed. 15(80). 7–15. 61 indexed citations
13.
Wang, Haifeng, Shuyan Zhang, Jiateng Zhong, et al.. (2013). The proteasome inhibitor lactacystin exerts its therapeutic effects on glioma via apoptosis: An in vitro and in vivo study. Journal of International Medical Research. 41(1). 72–81. 6 indexed citations
14.
Wang, Zhiwei, Hiroyuki Inuzuka, Jiateng Zhong, et al.. (2012). Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Letters. 586(10). 1409–1418. 125 indexed citations
15.
Yu, Chunyan, Xiaowei Huang, Ye Xu, et al.. (2012). Lysosome Dysfunction Enhances Oxidative Stress‐Induced Apoptosis through Ubiquitinated Protein Accumulation in Hela Cells. The Anatomical Record. 296(1). 31–39. 38 indexed citations
16.
Wang, Zhiwei, Jiateng Zhong, Hiroyuki Inuzuka, et al.. (2012). An Evolving Role for DEPTOR in Tumor Development and Progression. Neoplasia. 14(5). 368–375. 55 indexed citations
17.
Wang, Zhiwei, Hiroyuki Inuzuka, Jiateng Zhong, et al.. (2012). Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2. Oncotarget. 3(11). 1294–1300. 33 indexed citations
18.
Zhong, Jiateng, Ye Xu, Haowei Yi, et al.. (2012). The BH3 mimetic S1 induces autophagy through ER stress and disruption of Bcl-2/Beclin 1 interaction in human glioma U251 cells. Cancer Letters. 323(2). 180–187. 50 indexed citations
19.
Zhao, Yongxiang, et al.. (2010). Influence of Immunosuppressive Drugs on the Development of CD4+CD25high Foxp3+ T Cells in Liver Transplant Recipients. Transplantation Proceedings. 42(7). 2599–2601. 10 indexed citations
20.
Zhang, Hongyu, Xiaoxia Kong, Jinsong Kang, et al.. (2009). Oxidative Stress Induces Parallel Autophagy and Mitochondria Dysfunction in Human Glioma U251 Cells. Toxicological Sciences. 110(2). 376–388. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026